OOIR: Observatory of International Research

Papers

(The TQCC of Heart Rhythm is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-07-01 to 2026-07-01.)

Article	Citations
Implantable cardioverter-defibrillators for primary prevention during or early after hospitalization? A time to pause, reflect, and exercise sound clinical judgment	455
ID: 4121707 The Benefit of Signal Quality Assessment in Automated Ventricular Ectopic Beat Detection	213
Decisional conflict and defibrillator implantation choices among Black women and men with chronic systolic heart failure	193
Outcome of cardiac implantable electronic devices in pediatric heart transplant recipients	146
To the Editor — Ganglionated plexus modulation inducing vagal response during pulsed field ablation for atrial fibrillation: A blessing in disguise	132
Efficacy and safety of once-daily carvedilol in patients with atrial fibrillation: A randomized, double-blind, placebo-controlled trial	127
PO-01-181 A TOPSY TURVY CASE OF GADOLINIUM-BASED CONTRAST AGENT INDUCED QTC PROLONGATION AND TORSADES DE POINTES	126
MP-470544-008 AV MIRRORING IN SILICONE PACING LEADS WITH TRIBOLOGICAL WEAR – A CASE SERIES	119
PO-07-021 ARTIFICIAL-INTELLIGENCE BASED TRACKING OF ATRIAL FIBRILLATION WAVES TO IDENTIFY SITES OF ACUTE ABLATION SUCCESS	100
Alert notifications for impending patient demise—Widening the powers of automatic remote monitoring of cardiac implantable electronic devices	94
Type 3 long QT syndrome: Is the effectiveness of treatment with beta-blockers population-specific?	91
PO-04-066 DESIGN AND PRE-CLINICAL ASSESSMENT OF A NOVEL RETROGRADE AORTIC DELIVERY SHEATH TO AID ACCESS FOR LEFT VENTRICULAR MAPPING AND ABLATION	89
PO-04-170 AUTOMATED CT-BASED PREDICTION OF VENTRICULAR ARRHYTHMIA	85
PO-03-146 PREMATURE VENTRICULAR CONTRACTIONS IN CHILDREN AND YOUNG ADULTS: RISK FACTORS FOR LEFT VENTRICULAR DYSFUNCTION	72
PO-02-216 SEGMENTAL INCREASE IN HETEROGENEITY OF REPOLARIZATION CORRESPONDS TO REGIONS OF DECREASED INNERVATION AFTER MYOCARDIAL INFARCTION	70
CI-452767-3 MACHINE LEARNING-POWERED, DEVICE-EMBEDDED HEART SOUND MEASUREMENT CAN OPTIMIZE AV DELAY IN CRT PATIENTS	70
PO-05-119 PEAK FREQUENCY CAN BE EFFECTIVELY USED TO CHARACTERIZE ATRIAL REMODELING IN ATRIAL FIBRILLATION	60
PO-01-043 COMPARISON OF RISK SCORES FOR PREDICTION OF SUDDEN DEATH AND SUSTAINED VENTRICULAR TACHYCARDIA IN REPAIRED TETRALOGY OF FALLOT	59
PO-04-196 CORRELATION BETWEEN VENTRICULAR TACHYCARDIA CIRCUIT AND CARDIAC COMPUTED TOMOGRAPHY-DERIVED WALL THINNING FOR POSTINFARCTION VENTRICULAR TACHYCARDIA ABLATION	59
PO-01-065 DECREASE IN HEART RATE AND BRADYCARDIA PRECEDING IN-HOSPITAL CARDIAC ARREST	57
PO-01-141 REAL LIFE EXPERIENCE WITH PULSED FIELD ABLATION FOR RECURRENT VENTRICULAR ARRHYTHMIAS	57
PO-01-019 VASCULAR AGE PREDICTION USING CHEST X-RAYS	55
PO-04-122 PULSED FIELD ABLATION DOSE-RESPONSE SAFETY AND EFFICACY CHARACTERIZATION OF A NOVEL LARGE SPHERICAL TIP MAPPING AND CONTACT FORCE-SENSING CATHETER	54
PO-03-160 IS THERE A FUTURE FOR THE 90-DAY BLANKING PERIOD AFTER PULSED FIELD ABLATION: EARLY RECURRENCES IN THE PULSED AF TRIAL	51
PO-04-064 INVASIVE HAEMODYNAMIC ASSESSMENT SHOWS THE OBESITY-HFPEF PHENOTYPE IS COMMON AMONGST PATIENTS WITH SYMPTOMATIC AF	51

PO-01-079 SEX DIFFERENCES IN ELECTROGRAPHIC FLOW PHENOTYPES AND OUTCOMES IN PATIENTS UNDERGOING PULMONARY VEIN ISOLATION	48
PO-01-093 PREDICTORS OF ARRHYTHMIA IN THE INPATIENT POPULATION PRIMARILY HOSPITALIZED FOR SARS-COV-2; A RETROSPECTIVE LARGE-DATABASE ANALYSIS	48
PO-01-026 RIGHT ATRIAL APPENDAGE THROMBECTOMY USING ALPHAVAC TO FACILITATE ATRIAL FIBRILLATION (AFIB) ABLATION	47
PO-02-144 LEFT ATRIAL FUNCTIONAL AND TISSUE CHANGES AFTER PULMONARY VEIN ISOLATION IN ATRIAL FIBRILLATION PATIENTS - INITIAL RESULTS OF THE EVALUATE-PVI STUDY	47
PO-02-140 WITHDRAWN	46
PO-03-174 PREDICTORS OF PERMANENT PACEMAKER PLACEMENT IN PATIENTS UNDERGOING TRICUSPID VALVE SURGERY-A RETROSPECTIVE COHORT STUDY OF THE NATIONAL INPATIENT SAMPLE	45
MP-483499-007 MECHANISMS OF MITRAL ISTHMUS RECONNECTION AFTER MITRAL ISTHMUS ABLATION WITH AND WITHOUT VEIN OF MARSHALL ETHANOL INFUSION	44
PO-03-192 THE ASSOCIATION BETWEEN PACED LEFT VENTRICULAR ACTIVATION TIME AND CARDIAC REVERSE REMODELING IN HEART FAILURE PATIENTS WITH LEFT BUNDLE BRANCH BLOCK	43
PO-03-171 LEADLESS PACEMAKERS ARE UNAFFECTED BY RADIATION EXPOSURE AT CLINICALLY RELEVANT THERAPEUTIC DOSES USED IN ONCOLOGY	42
PO-03-164 INCIDENCE, PREDICTORS, AND INDICATIONS FOR PERMANENT PACEMAKER IMPLANTATION AFTER ORTHOTOPIC HEART TRANSPLANTATION	41
PO-02-064 IS THORACIC IMPEDANCE TRULY ACCURATE IN PREDICTING ACUTE DECOMPENSATIONS ACROSS DIFFERENT STAGES OF HEART FAILURE?	41
PO-02-192 FIRST REPORT OF STRENGTH-DURATION CURVES OBTAINED FROM PATIENTS IMPLANTED WITH A NOVEL DUAL-CHAMBER LEADLESS PACEMAKER SYSTEM	41
PO-01-036 ACCURACY OF FORWARD-SOLUTION COMPUTATIONAL ECG MAPPING FOR VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH ADULT CONGENITAL HEART DISEASE	40
PO-02-069 OUTCOMES OF LEFT BUNDLE BRANCH AREA PACING UPGRADE IN PATIENTS WITH RIGHT VENTRICULAR PACING-INDUCED CARDIOMYOPATHY	39
PO-02-184 IMCAP-AI STUDY: EVALUATION OF THE DIAGNOSTIC PERFORMANCE AND ORGANIZATIONAL IMPACT OF AN ILR ECG ANALYZER ALGORITHM IN CLINICAL PRACTICE	38
MP-470554-005 VERY SLOW ATRIOVENTRICULAR NODE REENTRY TACHYCARDIA MASQUERADING AS JUNCTIONAL RHYTHM: MECHANISM AND ELECTROPHYSIOLOGIC CHARACTERISTICS	37
MP-483492-003 SHORTER COUPLED PREMATURE ATRIAL COMPLEXES LEAD TO ACUTE ATRIAL MECHANICAL DYSFUNCTION AND CHRONIC INDUCIBLE ATRIAL FIBRILLATION IN A SWINE MODEL	37
PO-06-125 ZERO-FLUOROSCOPY CATHETER ABLATION IN PREGNANT: EVALUATION OF SAFETY, FEASIBILITY AND EFFICACY	36
PO-06-072 BIPOLAR ABLATION FOR SEPTAL VENTRICULAR TACHYCARDIA IN A PATIENT WITH CARDIAC SARCOIDOSIS	36
PO-06-117 CLINICAL OUTCOMES OF PROSPECTIVE COMPUTATIONAL 12-LEAD ECG MAPPING GUIDED PVC ABLATION	36
MP-483493-004 SUPERIORITY OF LONG-DURATION RADIOFREQUENCY ABLATION TO THE USE OF HALF-NORMAL SALINE IRRIGATION IN INCREASING LESION SIZE	36
PO-03-121 THE EFFECT OF DIAGNOSIS TO ABLATION TIME IN PATIENTS UNDERGOING CATHETER ABLATION FOR PERSISTENT ATRIAL FIBRILLATION	35
PO-02-156 THE RISE OF LEFT BUNDLE BRANCH AREA "PACE AND ABLATE"; AV NODAL ABLATION OUTCOMES, WHERE ARE WE NOW?	35
PO-02-081 EXPLORING THE ROLE OF HEART-TORSO GEOMETRY IN NON-INVASIVE ELECTROCARDIOGRAPHIC IMAGING ACCURACY AND POTENTIAL GEOMETRIC CALIBRATION TECHNIQUES	35
Anatomy terminology—Note from the Editors	35
MP-453089-5 CLINICAL BENEFITS OF EARLY LEFT BUNDLE BRANCH PACING IN HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION AND LEFT BUNDLE BRANCH BLOCK	34
MP-453092-7 THE IMPACT OF ELECTROANATOMICAL MAPPING AND VT SUBSTRATE ABLATION ON PRIMARY AND SECONDARY PREVENTION ICD INDICATION IN PATIENTS WITH REPAIRED TETRALOGY OF FALLOT	34
PO-FP-083 ARRHYTHMIC EVENT RISK AND NEONATAL OUTCOMES IN PREGNANT AND POSTPARTUM CPVT PATIENTS	33
PO-05-106 THREE-DIMENSIONAL INTRACARDIAC ECHOCARDIOGRAPHY TO GUIDE LEFT ATRIAL APPENDAGE AND PERI-DEVICE LEAK CLOSURE: FEASIBILITY OF RIGHT-SIDED IMAGING	33
PO-01-180 MECHANISMS OF PULMONARY ARTERIAL HYPERTENSION-INDUCED ATRIAL FIBRILLATION IN THE RIGHT HEART: INSIGHTS FROM MULTI-SCALE MODELS OF THE HUMAN ATRIA	33
PO-01-146 SUCCESSFUL MANAGEMENT OF MULTIFOCAL ATRIAL TACHYCARDIA WITH TRAMETINIB IN COSTELLO SYNDROME	33
PO-01-103 IMPACT OF FILTERED IMPEDANCE DROP ON ATRIAL LESION SIZE PREDICTION	33
Defining the holy grail of left bundle branch area pacing—does the pulse width matter?	33
Predicting decline in left ventricular function after new-onset left bundle branch block	33
Diltiazem, direct oral anticoagulants, and risk of major bleeding in patients with atrial fibrillation	32
PO-02-081 REDUCTION IN ARIAL TACHYCARDIA/ATRIAL FIBRILLATION IN SUSTAINED ATRIAL FIBRILLATION PATIENTS AFTER ATRIOVENTRICULAR JUNCTION ABLATION: A RETROSPECTIVE REAL-WORLD ANALYSIS	32
Reply to the Editor — Risk of atrial arrhythmias in arrhythmogenic right ventricular cardiomyopathy patients undergoing ventricular tachycardia ablation	32
PO-05-200 FEASIBILITY AND ACCEPTABILITY OF A SELF-CARE INTERVENTION FOR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) PATIENTS: A “SYSTEMS CHECK”	32
PO-04-016 CALCULATION OF LOADING DOSE OF HEPARIN DURING ATRIAL FIBRILLATION ABLATION IN PATIENTS RECIEVING UNINTERRUPTED DIRECT ORAL ANTICOAGULANT AGENTS	31
PO-02-038 LACK OF ATRIAL BRANCH PERFUSION DURING ACUTE ISCHEMIA IS NOT ASSOCIATED WITH NEW-ONSET ATRIAL FIBRILLATION DURING STEMI	31
PO-01-103 PFA TO THE RESCUE: TERMINATION OF RF RESISTANT RVOT VT WITH A SINGLE PFA APPLICATION	31
PO-01-064 CONDUCTION SYSTEM PACING TO RESYNCHRONIZE AND IMPROVE THE SYSTOLIC PERFORMANCE OF THE SYSTEMIC RIGHT VENTRICLE IN A PATIENT WITH CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	31
PO-05-076 GENETIC DEPENDENCY OF ATRIAL FIBRILLATION-ASSOCIATED RISK GENES ACROSS TISSUE TYPES: DISCOVERING NOVEL THERAPEUTIC TARGETS	31
HF-499653-005 CHARACTERIZATION OF RIGHT BUNDLE BRANCH BLOCK WITH INVASIVE MAPPING: IMPLICATIONS FOR CONDUCTION SYSTEM PACING	31
PO-02-088 THE IMPACT OF POSTOPERATIVE ATRIAL FIBRILLATION AFTER CARDIAC SURGERY	30
PO-04-028 PULSED FIELD ABLATION FOR PULMONARY VEIN ISOLATION WITH OR WITHOUT POSTERIOR WALL ISOLATION IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION: A MULTICENTER RETROSPECTIVE STUDY	30
PO-05-031 CARDIAC SYMPATHETIC NEUROPATHOLOGY SUPPORTS THE MULTICELLULARITY OF ARRHYTHMOGENIC CARDIOMYOPATHY	30
PO-05-214 THE RELATIONSHIP BETWEEN WIDE ANTRAL CIRCUMFERENTIAL ABLATION LINE LENGTH AND RECURRENCE OF ATRIAL FIBRILLATION POST-PULMONARY VEIN ISOLATION	30
PO-04-145 IMPACT OF TIME FROM ATRIAL FIBRILLATION DIAGNOSIS TO ABLATIVE THERAPY ON DEATH AND HOSPITALIZATION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: RESULTS BY AGE AND SEX FROM THE INTERMOU	30
PO-05-020 ARTERIAL BAROREFLEX DESENSITIZATION IS THE MECHANISM OF SYMPATHETIC OVERLOAD AND PARASYMPATHETIC SUPPRESSION IN PREMATURE VENTRICULAR CONTRACTION-INDUCED CARDIOMYOPATHY	30

EN-499638-002 PHARMACOLOGIC RESCUE OF LOSS-OF-FUNCTION CARDIAC SODIUM CHANNELOPATHIES	30
PO-FP-023 ASSOCIATIONS BETWEEN DEVICE-MEASURED 24-HOUR MOVEMENT BEHAVIORS AND CARDIAC CONDUCTION DISEASE IN THE UK BIOBANK: A PROSPECTIVE COHORT STUDY	30
PO-03-073 1-YEAR AND 3-YEAR OUTCOME COMPARISON BETWEEN RADIOFREQUENCY AND CRYOBALLOON ABLATION IN ATRIAL FIBRILLATION	29
PO-CES-01 OPTOGENETICS FOR INVESTIGATION OF ARRHYTHMIA MECHANISMS AND TREATMENTS IN A HUMANIZED RECELLULARIZED ATRIAL MODEL	29
PO-06-128 SHORT-TERM OUTCOMES AND PERFORMANCE OF DUAL-CHAMBER LEADLESS PACEMAKERS: A SINGLE-CENTRE EXPERIENCE WITH 60 PATIENTS	29
PO-04-170 WITHDRAWN	29
PO-07-031 UNCOVERING WHAT IS RIGHT IN FRONT OF US: QDOT MICRO™ FOR ACCESSORY PATHWAY ABLATION	29
PO-05-132 SGLT2 INHIBITORS ATTENUATE ATRIAL CARDIOMYOPATHY AND REDUCE AF SUSCEPTIBILITY IN NPPA KNOCK-IN RATS	29
PO-04-010 TEMPORAL SEQUENCE OF OBSTRUCTIVE SLEEP APNEA AND ATRIAL FIBRILLATION DEVELOPMENT IMPACTS THE PROGNOSIS AND THE INCIDENCE OF MAJOR CARDIOVASCULAR EVENTS	28
PO-03-081 VISUALIZATION AND CHRONIC ASSESSMENT OF ELECTRICAL FIELD TAGS FOR PULSED FIELD ABLATION OF PULMONARY VEINS WITH THE SECOND-GENERATION PENTASPLINE CATHETER	28
PO-07-035 DEEP LEARNING-BASED PREDICTION OF AVNRT ABLATION TARGETS FROM INTRACARDIAC ELECTROGRAMS	28
PO-02-017 POSTPARTUM DIRECT ORAL ANTICOAGULANTS OR ASPIRIN IN PREGNANT WOMEN WITH ATRIAL FIBRILLATION: A PROPENSITY SCORE-MATCHED ANALYSIS	28
PO-02-201 LONG-TERM USE OF ORAL ANTICOAGULATION AFTER WATCHMAN IMPLANTATION	28
PO-02-044 EFFICACY AND DRUG-RELATED COMPLICATIONS OF ANTICHOLINERGIC DRUGS FOR VAGAL REACTION PREVENTION DURING PULSED FIELD ABLATION	28
PO-06-033 LONG-TERM OUTCOMES OF TRIPLE-SITE VERSUS DUAL-SITE CARDIAC RESYNCHRONIZATION THERAPY USING TEMPORARY PACING TO GUIDE INDIVIDUALIZED IMPLANTATION	27
PO-07-107 CRYOBALLON PULMONARY VEIN ISOLATION (PVI) IN SITUS AMBIGUOUS AND DEXTROCARDIA	27
PO-06-032 LV SIZE: AN ANONYMOUS MODULATOR OF ELECTRICAL OPTIMIZATION IN CRT	27
PO-02-118 CLUSTERING BASED ON CARDIAC AND BRAIN CENTRAL AUTONOMIC NETWORK DATA STRATIFIES ATRIAL FIBRILLATION PATIENTS BY COMORBID DEPRESSION AND STROKE RISK	27
PO-06-070 CURRENT OF INJURY ON THE RIGHT VENTRICULAR ENDOCARDIUM BEFORE ENTRAPMENT OR SUCCESSFUL PLACEMENT OF THE LEFT BUNDLE BRANCH AREA PACING LEAD	27
PO-06-191 PREDICTORS OF PACEMAKER DEPENDENCY FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION	26
PO-06-090 THE INCIDENCE OF FAILURE OF REMAINING FUNCTIONAL LEADS AND NEWLY IMPLANTED LEADS AFTER TRANSVENOUS LEAD EXTRACTION	26
PO-07-070 STELLATE GANGLION BLOCK IN THE MANAGEMENT OF EMERGENT VENTRICULAR ARRHYTHMIAS: OUTCOMES FROM A SINGLE CANADIAN CENTER	26
PO-07-064 STELLATE GANGLION BLOCK AS AN ADJUNCT TREATMENT OF DRUG-REFRACTORY ELECTRIC STORM: A PERSPECTIVE OF A TERTIARY CENTER	26
PO-06-006 HIGH ATRIAL SEPTAL IMPLANTS DEMONSTRATE REDUCED ACUTE INACTIVATION RATES AND IMPROVED AV CONDUCTION WHEN COMPARED TO APPENDAGE IMPLANTS	26
PO-03-208 COMPARISON OF LESION FORMATION WITH TEMPERATURE CONTROLLED ABLATION USING QDOT CATHETER	26
MP-470551-004 EARLY ROLE OF NEUTROPHILS IN THE PATHOGENESIS OF ARRHYTHMOGENIC CARDIOMYOPATHY	25
CI-482892-002 DEFIBRILLATION SUCCESS WITH A SECOND GENERATION INTERCOSTAL EXTRAVASCULAR ICD LEAD AND COMMERCIALLY AVAILABLE LEFT PECTORAL PULSE GENERATORS	25
EP News: Pediatric and Congenital Electrophysiology	25
Atrial fibrillation’s hidden compass: The left atrium and the future of risk stratification	25
Leadless pacing after transvenous lead extraction: Are we out of the woods?	24
Supraventricular tachycardia with double trouble	24
PO-04-144 IMPACT OF AGE ON ATRIAL ARRHYTHMIA OUTCOMES AFTER PERCUTANEOUS ASD CLOSURE	24
PO-03-158 PEDIATRIC CARDIAC SCREENING DATA WAREHOUSE: A NATIONAL PUBLIC HEALTH RESOURCE	24
Fifty years later, I was the recipient of the medical innovation I invented	24
PO-03-051 EXPEDITED SAME DAY DISCHARGE PROTOCOL IS SAFE FOR PATIENTS UNDERGOING CARDIAC IMPLANTABLE ELECTRONIC DEVICE (CIED) IMPLANTATION	24
EP News: Pediatric and Congenital Electrophysiology	23
PO-05-012 REPOLARIZATION CHANGES FOLLOWING CONDUCTION SYSTEM PACING EVALUATED BY ULTRA-HIGH-FREQUENCY ELECTROCARDIOGRAPHY	23
PO-03-015 HIS BUNDLE PACING: OUTCOME AFTER 10-YEARS FOLLOW-UP	23
PO-02-224 CONDUCTION VELOCITIES DETERMINED BY NON-INVASIVE ELECTROCARDIOGRAPHIC IMAGING PREDICT ARRHYTHMIA-FREE SURVIVAL AFTER PULMONARY VEIN ISOLATION	23
AP-452680-5 SPEECH-INDUCED ATRIAL TACHYCARDIA: A RARE PHENOMENON DOCUMENTED DURING PACEMAKER DEVICE INTERROGATION	23
PO-03-222 CURRENT TRENDS AND OUTCOMES OF SUDDEN CARDIAC ARREST IN YOUNG ADULTS IN THE USA: INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE	23
Wide complex tachycardia with atrioventricular dissociation? Not so fast buddy	23
Unusual responses of a short RP tachycardia to His-refractory ventricular premature depolarizations: What is the mechanism?	23
PO-04-092 SAFETY AND EFFICACY OF DIFFERENT FIELD STRENGTHS OF PULSED-FIELD ABLATION IN ACHIEVING DURABLE CAVOTRICUSPID ISTHMUS BLOCK: A PRECLINICAL STUDY	23
PO-03-093 EFFECT OF CATHETER ABLATION FOR ATRIAL FIBRILLATION ON LEFT ATRIAL FUNCTION AND LEFT VENTRICULAR DIASTOLIC FILLING	23
PO-03-055 INCIDENCE OF INAPPROPRIATE PAUSE DETECTION WITH REMOTE CARDIAC MONITORING BY INSERTABLE CARDIAC MONITOR, A REAL-WORLD STUDY	23
PO-03-094 IMAGE INTEGRATION IN VENTRICULAR TACHYCARDIA (VT) ABLATION USING SENSE2 PROTOCOL MAPPING	23
PO-03-026 ACUTE PROCEDURAL AND INTERMEDIATE-TERM LEAD PERFORMANCE OF LEFT BUNDLE BRANCH AREA PACING	23
PO-03-007 CROSS VALIDATION OF A MACHINE LEARNING ALGORITHM DESIGNED TO IDENTIFY PULMONARY VEIN SIGNALS USING COMPETING TRAINING DATA	23
Atrial resynchronization with Bachmann bundle pacing—time to think outside the appendage?	22
Access to electrophysiologic care for Medicare beneficiaries across the United States: Travel distance and time to nearest clinician, 2013–2020	22
PO-02-047 OUTCOMES OF CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE REMOVAL WITHOUT REIMPLANTATION IN PEDIATRIC PATIENTS	22
PO-04-110 MAPPING TRENDS IN AVNRT ABLATION: AN INTERNATIONAL ANALYSIS	22
Table of Contents	22
Artificial intelligence for detection of ventricular oversensing: Machine learning approaches for noise detection within nonsustained ventricular tachycardia episodes remotely transmitted by pacemaker	22
Mortality and readmissions after ventricular tachycardia ablation: An analysis of inpatient and outpatient state databases	22
Novel electrocardiographic observations during left bundle branch area pacing: Multiple QRS transition, supernormality, concealed capture, virtual electrode effect, and other phenomena	22
PO-02-089 EMPIRIC VEIN OF MARSHALL ETHANOL INFUSION IN PATIENTS UNDERGOING REPEAT CATHETER ABLATION WITH DURABLY ISOLATED PULMONARY VEINS	22
PO-02-151 INCREASED VENTRICULAR ARRHYTHMIAS IN A MOUSE MODEL OF HYPERTROPHIC CARDIOMYOPATHY	22
PO-04-233 MULTIDISCIPLINARY APPROACHES TO TREAT VENTRICULAR ARRHYTHMIAS WITH RADIOABLATION AND CARDIAC SYMPATHECTOMY (MAVERICS)	22
PO-02-175 AI ENABLES SIGNIFICANT REDUCTION OF CLINIC REVIEW BURDEN FOR LEGACY ICMS	22
Cardiac resynchronization therapy with triple fusion using the SyncAV dynamic algorithm compared to conventionally optimized biventricular pacing: Results from the multicentric, randomized, double-bli	22
PO-02-199 A NOVEL FINDING: SERUM MICRORNA-122 CORRELATES WITH LEFT ATRIAL SUBSTRATE IN PATIENTS WITH ATRIAL FIBRILLATION	22
PO-04-033 CARDIONEUROABLATION IN A WOMAN WITH ICTAL-INDUCED CARDIAC ASYSTOLE	22
PO-03-138 REAL-WORLD EXPERIENCE UTILIZING THE NUVISION 4D INTRACARDIAC ECHOCARDIOGRAPHY CATHETER FOR LEFT TRIAL APPENDAGE CLOSURE	22
Empirical slow pathway ablation in patients with paroxysmal palpitations and pounding in the neck: A 15-year follow-up	21
PO-FPI-294 IMPACT OF ORAL ANTICOAGULANT DISCONTINUATION ON QUALITY OF LIFE IN PATIENTS AFTER SUCCESSFUL ATRIAL FIBRILLATION ABLATION: RESULTS FROM THE ALONE-AF TRIAL	21
PO-05-310 SOCIODEMOGRAPHIC AND GENDER DISPARITIES IN ATRIAL FLUTTER ABLATION RATES: A NATIONWIDE STUDY OF THE USA	21
PO-02-244 SILENCING THE VAGUS: INTRACARDIAC ECHO GUIDED CARDIONEUROABLATION FOR MALIGNANT BRADYCARDIA AFTER TRAUMATIC BRAIN INJURY	21
Factors associated with heart failure events in patients with new-onset persistent left bundle branch block at discharge after transcatheter aortic valve replacement	21
PO-04-255 TRAMETINIB AS POTENTIAL OFF-LABEL THERAPY TO PREVENT DISEASE IN A MOUSE MODEL OF SARCOMERIC HYPERTROPHIC CARDIOMYOPATHY	21
PO-03-304 INTRACARDIAC ELECTROGRAM RECORDING OF BACHMANN'S BUNDLE DURING INTERMITTENT INTERATRIAL BLOCK IN A PATIENT WITH VARYING P WAVE MORPHOLOGIES: LOCALIZING THE SITE OF INTERATRIAL CONDUCTION DEL	21
PO-04-029 VERY HIGH POWER VS. HIGH POWER SHORT DURATION CATHETER ABLATION OF PAROXYSMAL ATRIAL FIBRILLATION – PROCEDURAL RESULTS FROM A RANDOMIZED TRIAL	21
PO-01-205 LEFT LATERAL PULSE GENERATOR PLACEMENT RECOMMENDATIONS FOR THE PARASTERNAL EV-ICD SYSTEM	21
CE-534534-005 LONG-TERM PERFORMANCE OF DIFFERENT TREATMENT APPROACHES IN BRUGADA SYNDROME	21
PO-03-012 PATIENT-LEVEL OPTIMIZATION OF LOOP RECORDER TRANSMISSIONS: A LONGITUDINAL ANALYSIS OF 26 PATIENTS ACHIEVING 71% REDUCTION	21
PO-05-324 ONE YEAR FOLLOW UP COSTS OF RF VS. PFA FOR ATRIAL FIBRILLATION ABLATION	21
PO-FPI-016 PROGNOSTIC SIGNIFICANCE OF AF BURDEN QUANTIFIED BY CONTINUOUS REMOTE MONITORING IN PATIENTS WITH CARDIAC IMPLANTABLE DEVICES	20
PO-04-149 SAFETY AND CLINICAL OUTCOMES OF AN INDEX ENDO-EPICARDIAL STRATEGY, UTILISING EPICO2,FOR ANTIARRHYTHMIC RESISTANT VENTRICULAR ARRHYTHMIAS	20
PO-05-276 PROCEDURAL & CLINICAL OUTCOMES OF ADDITIONAL ATRIAL ARRHYTHMIAS ABLATED DURING PULSED FIELD ABLATION OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION	20

PO-03-267 FEASIBILITY AND SHORT-TERM OUTCOMES OF DISTAL HIS BUNDLE PACING	20
PO-FPII-311 LEAD V8 AS A SIMPLE NON-INVASIVE TOOL FOR ASSESSING LV ACTIVATION DELAY AND GUIDING LEAD PLACEMENT ACROSS CONDUCTION ABNORMALITIES	20
PO-04-293 SAFETY AND EFFICACY OF ANTITHROMBOTIC THERAPY WITH LOW-DOSE APIXABAN AFTER WATCHMAN FLX LEFT ATRIAL APPENDAGE OCCLUSION DEVICE IMPLANTATION	20
PO-01-041 SAFETY OF THE USE OF THE VARIABLE LOOP CIRCULAR CATHETER FOR PATIENTS WITH ATRIAL FIBRILLATION AND CARDIAC DEVICES	20
PO-CES-01 PANORAMIC OPTICAL AND VOLUMETRIC ULTRASOUND IMAGING OF ELECTROMECHANICS IN CONTRACTING HEARTS	20
PO-04-254 A HUMAN IPSC-DERIVED SINOATRIAL NODE ORGANOID MODEL RECAPITULATES FIBROSIS-DRIVEN SICK SINUS SYNDROME AND IDENTIFIES TANSHINONE IIA AS A POTENTIAL THERAPEUTIC AGENT	20
PE-534543-001 FEASIBILITY OF A MODIFIED MINIATURE DUAL CHAMBER EPICARDIAL PACING SYSTEM FOR PEDIATRIC USE	20
PO-FPI-017 ESTIMATING APNEA HYPOPNEA INDEX USING ECG AND DEEP NEURAL NETWORKS	20
PO-04-013 NATIONWIDE SAFETY ASSESSMENT OF OVER 20,000 PULSED FIELD AND 10,000 THERMAL ABLATIONS FOR ATRIAL FIBRILLATION IN THE UNITED STATES	20
PO-03-063 NOVEL SOFTWARE PLATFORM UTILIZES IMPLANTABLE CARDIAC MONITOR SECGS FOR EXTENDED QTC AND RHYTHM SURVEILLANCE IN AF PATIENTS ON ANTIARRHYTHMIC DRUGS: A CLINICAL PILOT	19
PO-03-197 THE COMPETING RISK OF ARRHYTHMIC EVENTS AND NON-ARHYTHMIC MORTALITY BY AGE: ANALYSIS FROM THE APPRAISE-ATP TRIAL	19
PO-01-254 REAL WORLD DATA OF CARDIAC RESYNCHRONIZATION THERAPY AMONG MID-RANGE QRS DURATION USING THE JPN-CRT DATA IN ASIA	19
PO-05-017 A MASSIVE STEMI: OR A CATASTROPHIC CONSEQUENCE TO ABLATION?	19
PO-03-061 PREDICTION OF ATRIAL FIBRILLATION FROM 10-SECOND AND 60-SECOND AMBULATORY ECG SEGMENTS USING A SELF-SUPERVISED FOUNDATIONAL MODEL	19
PO-05-269 POST-ABLATION SCAR BURDEN DISCRIMINATES RECURRENCE PATTERN: ATRIAL FLUTTER VS ATRIAL FIBRILLATION	19
PO-04-022 COMPREHENSIVE RESULTS FROM AN ITERATIVE FIRST-IN-HUMAN INTEGRATED INTRACARDIAC ECHOCARDIOGRAPHY TRIAL	19
PO-02-186 VENTRICULAR ARRHYTHMIA ORIGINATING FROM THE EPICARDIAL ASPECT OF THE RIGHT VENTRICULAR APEX: A CASE REPORT	19
PO-03-235 OUTCOMES OF CONDUCTION SYSTEM PACING IN COMPLETE HEART BLOCK: EVIDENCE FROM A LARGE REAL-WORLD COHORT	19
PO-05-038 ANTI-INFLAMMATORY AND AUTONOMIC EFFECTS OF BAROREFLEX ACTIVATION THERAPY IN HFREF: A CASE SERIES	19
PO-02-288 ADVANCED AGE PROMOTES ATRIAL ECTOPY AND ATRIAL FIBRILLATION STABILIZATION: THE ROLE OF ACTIVATED COAGULATION FACTORS AND THE ATRIAL INFLAMMASOME	19
PO-01-331 A PROSPECTIVE MULTICENTER STUDY OF MAPPING AND ABLATION OF FOCAL DRIVERS IN REPEAT ATRIAL FIBRILLATION ABLATION	18
PO-02-035 RIGHT ATRIAL CARDIOMYOPATHY AS THE DOMINANT STRUCTURAL PREDICTOR OF AF RECURRENCE AFTER ABLATION	18
PO-05-019 BEYOND VASOSPASM: PVC-INITIATED POLYMORPHIC VENTRICULAR TACHYCARDIA AND VENTRICULAR FIBRILLATION STORM AFTER 5-FLUOROURACIL THERAPY	18
PO-03-213 CLINICAL IMPACT OF LEADLESS PACEMAKER IMPLANTATION ON TRICUSPID REGURGITATION	18
PO-03-071 GLP-THERAPY USE AND LOWER BRADYCARDIA RISK IN DIABETES: INSIGHTS FROM A LARGE REAL-WORLD COHORT	18
PO-02-093 DOES ATRIAL ECTOPY PREDICT ATRIAL FIBRILLATION RECURRENCE POST-ABLATION? A RETROSPECTIVE OBSERVATIONAL STUDY	18
PO-04-120 CATHETER ABLATION OF VENTRICULAR TACHYCARDIAS IN STRUCTURAL HEART DISEASE USING A DUAL-ENERGY LATTICE-TIP FOCAL CATHETER	18
PO-02-101 NUMBER NEEDED TO ENTRAIN AND PROXIMITY TO VENTRICULAR TACHYCARDIA RE-ENTRANT CIRCUITS	18
PO-01-337 NONINVASIVE NEUECG CAPTURES DIET INDUCED SYMPATHETIC DYSFUNCTION WITH HISTOLOGIC CONFIRMATION IN THE STELLATE GANGLION	18
CI-534529-001 RETRIEVAL EXPERIENCE OF DUAL-CHAMBER, HELIX-FIXATION LEADLESS PACEMAKERS	18
PO-05-040 ELECTRICAL DATA AND EGM MORPHOLOGY WITH ACUTE THROMBUS FORMATION ON HELIX OF LEADLESS VENTRICULAR PACEMAKERS	18
PO-02-332 ELEVATED IGE IS ASSOCIATED WITH ATRIAL FIBRILLATION AND PROMOTES CARDIAC SYMPATHETIC REMODELING: A TRANSLATIONAL STUDY	18
PO-01-209 TRICUSPID VALVE FUNCTION AFTER HELIX-FIXATION LEADLESS PACEMAKER IMPLANTATION: A SINGLE-CENTER EXPERIENCE	18
PE-534544-005 LONG-TERM ARRHYTHMIA AFTER CONE REPAIR OF EBSTEIN ANOMALY IN PEDIATRIC PATIENTS	18
PO-02-047 HIGHER DIETARY FIBER INTAKE IS ASSOCIATED WITH LOWER RESTING HEART RATE AND REDUCED TACHYCARDIA PREVALENCE IN U.S. ADULTS: ANALYSIS OF NHANES 2017–2018	18
PO-01-009 SAFETY OF PULSED FIELD ABLATION FOR ATRIAL FIBRILLATION IN PATIENTS WITH CARDIAC IMPLANTABLE ELECTRONIC DEVICES: INSIGHTS FROM THE PROSPECTIVE MULTICENTER DISRUPT-AF REGISTRY	18
PO-03-119 EARLY VENTRICULAR ARRHYTHMIA RISK AFTER ACUTE PERICARDITIS: A PROPENSITY MATCHED COHORT ANALYSIS	18
PO-02-103 LONG-TERM FOLLOW-UP OF CARDIAC SYMPATHETIC DENERVATION FOR REFRACTORY VENTRICULAR ARRHYTHMIAS: A SINGLE-CENTER RETROSPECTIVE STUDY	18
Electrophysiologic characteristics and durability of index pulsed field ablation lesions from redo procedures for atrial arrhythmia recurrences	17
Spatial ventricular gradient is associated with pacing-induced cardiomyopathy	17
Managing vagal responses induced by pulsed field ablation: Go right first?	17
PO-FPII-298 NOVEL FIXED HELIX STYLET DRIVEN LEAD FOR LBBAP: SHORT-TERM SAFETY AND PERFORMANCE OF THE SOLIA CSP S PACEMAKER LEAD	17
PO-02-239 IT’S JUST, A LITTLE TOUCH…PERMANENT MECHANICAL EFFECT ON AN UNUSUAL ATRIAL FOCUS IN A CHILD	17
Heart Rhythm 2026 Abstract Reviewers	17
PO-06-045 LEFT BUNDLE BRANCH AREA PACING VERSUS RIGHT VENTRICULAR PACING IN POST-TAVR PATIENTS: A RETROSPECTIVE PROPENSITY-MATCHED ANALYSIS	17
Association of frailty with outcomes of patients undergoing transvenous lead removal for cardiac implantable electronic device infections in the United States	17
Age-stratified outcomes of transvenous lead extraction: A 5090-patient experience from the ExTRACT registry	17
14-3-3ε/YWHAE regulates the transcriptional expression of cardiac sodium channel NaV1.5	17
PO-CES-08 AI-ENABLED ECG PREDICTS FUTURE ONSET OF ATRIAL ARRHYTHMIAS IN PEDIATRIC AND CONGENITAL HEART DISEASE	17
PO-02-333 ATRIAL GENE THERAPY TARGETING PARASYMPATHETIC SIGNALING RESULTS IN ELECTROGRAM RECURRENCE INCREASE INDICATING STABILIZATION OF ROTATIONAL DRIVERS IN ATRIAL FIBRILLATION CANINE MODEL	17
PO-03-151 ARRHYTHMIA AND QT PROLONGATION PROFILE OF OSIMERTINIB IN EGFR-MUTATED LUNG CANCER: A PROPENSITY-MATCHED REAL-WORLD ANALYSIS	17
Safety of left atrial appendage amputation in cardiac surgery patients without atrial fibrillation	17
Ventricular arrhythmias in patients with hypertrophic cardiomyopathy: Prevalence, distribution, predictors, and outcome	17
PO-FP-011 DETECTION OF ACUTE-ELECTRICALLY SILENT GAPS IN LESION USING A UNIPOLAR LOCAL SIGNAL ENERGY ALGORITHM IN A PORCINE MODEL OF PULMONARY VEIN PF OR RF ISOLATION	17
PO-05-283 FIRST-IN-HUMAN EXPERIENCE AND SIX-MONTH OUTCOMES USING A NOVEL SMALL-BALLOON PULSED-FIELD ABLATION CATHETER IN PERSISTENT ATRIAL FIBRILLATION	17
PO-04-329 IMPACT OF VERICIGUAT ON VENTRICULAR AND ATRIAL ARRHYTHMIC OUTCOMES IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION: A SYSTEMATIC REVIEW AND META-ANALYSIS	17
PO-02-163 IMPACT OF TRANSTHORACIC ECHOCARDIOGRAPHIC PARAMETERS ON THE RISK FOR LEFT ATRIAL APPENDAGE THROMBUS: A RETROSPECTIVE COHORT STUDY	17
PO-02-203 SUCCESSFUL ABLATION OF ELECTRICAL STORM IN BURNT-OUT ARVC WITHOUT HEMODYNAMIC SUPPORT	17
Association between modifiable risk factors and bradyarrhythmia: A Mendelian randomization study	16
Wavefront curvature analysis derived from preprocedural imaging can identify the critical isthmus in patients with postinfarcted ventricular tachycardia	16
Comparison of left atrial appendage occlusion using transesophageal echocardiography vs 3-dimensional intracardiac echocardiography: Insights from a single-center NCDR registry	16
Features and electrophysiologic behavior of AV nodal structure potential recorded in humans	16
Early trends in leadless pacemaker implantation: Evaluating nationwide in-hospital outcomes	16
The anatomy of atrial conduction: A review of anatomic landmarks integrated with computed tomographic virtual dissection to provide a road map for right atrial pacing	16
Efficacy and safety of a novel size-adjustable cryoballoon vs conventional cryoballoon: Results from the CONTRAST-CRYO II randomized clinical trial	16
To the Editor— Phrenic nerve injury after pulsed-field ablation: Quantification of symptom burden	16
Pulsed field ablation for incessant scar-related ventricular tachycardia: First US report	16
Endothelial function improvement and the outcomes after catheter ablation of persistent atrial fibrillation	16
Cholesterol profiles and cholesterol-lowering medication in relation to the incidence of atrial fibrillation	16
PO-02-192 OUTCOMES OF LEFT ATRIAL APPENDAGE OCCLUSION IN PATIENTS WITH HEART FAILURE: A 5-YEAR PROPENSITY MATCHED ANALYSIS	16
Single antiplatelet therapy vs oral anticoagulation monotherapy in patients with atrial fibrillation and coronary artery disease after successful catheter ablation: A target trial emulation	16
Arrhythmia substrates accessible from the aortic root and immediate sub-aortic areas: Mapping and ablation	16
The frequency of gene variant reclassification and its impact on clinical management in the inherited arrhythmia clinic	16
Safety of magnetic resonance imaging in patients with surgically implanted permanent epicardial leads	16
Delta QRS and outcomes post CRT in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial	16
PO-06-203 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR FAILURE DUE TO HIGH-VOLTAGE IMPEDANCE ABNORMALITY CAUSING MONOPHASIC SHOCKS AND DEFIBRILLATION FAILURE	16
Risk factors associated with ventricular fibrillation during first ST-elevation myocardial infarction: Individual participant data analysis of 3 prospective case-control studies	16
Electroanatomic localization of idiopathic ventricular arrhythmia origins in the left ventricular outflow tract	16
Evaluation of noninvasive isochronal late activation mapping in scar-related ventricular tachycardia with electrocardiographic imaging against contact mapping	16
PO-01-173 VAGAL NERVE STIMULATION REDUCES INTERSTITIAL VENTRICULAR NEUROPEPTIDE Y RELEASE VIA ACTIVATION OF PRESYNAPTIC SYMPATHETIC MUSCARINIC RECEPTORS	15
PO-04-123 BIOMARKERS IN EARLY AND LATE PERIOD AFTER RADIOFREQUENCY AND PULSED FIELD CATHETER ABLATION OF ATRIAL FIBRILLATION	15
PO-02-034 CARDIOGENIC SHOCK AND PNEUMOPERICARDIUM: A RARE PRESENTATION OF ATRIOESOPHAGEAL FISTULA	15
PO-04-127 COLCHICINE TREATMENT PREVENTS ATRIAL FIBRILLATION INCIDENCE IN A RAT MODEL OF CATHETER ABLATION: IDENTIFICATION OF SEX-SPECIFIC DIFFERENCES	15
PO-05-181 EPICARDIAL CONDUCTION VELOCITY AND ANISOTROPIC PROPERTIES OF FIBRILLATION WAVES IN PATIENTS WITH ACUTELY INDUCED AND LONG-STANDING PERSISTENT ATRIAL FIBRILLATION	15
PO-03-001 ARTIFICIAL INTELLIGENCE FOR IMPROVED ATRIAL FLUTTER/ATRIAL TACHYCARDIA DETECTION IN INSERTABLE CARDIAC MONITOR	15
18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context	15
HeartRhythm 2025: State of the Journal	15
PO-02-138 CAVOTRICUSPID ISTHMUS ABLATION USING A NOVEL SINGLE-SHOT LINEAR HEXAPOLAR PULSED FIELD ABLATION CATHETER SYSTEM	15
PO-04-132 DISTRIBUTION AND TEMPORAL PROGRESSION OF LEFT ATRIAL POSTERIOR WALL (PW) LOW-VOLTAGE AREAS (LVA)	15
PO-03-010 BACK TO THE FUTURE: ARTIFICIAL INTELLIGENCE-ENABLED SINGLE-LEAD AMBULATORY ECG CAN UNMASK CONDUCTION TISSUE DISEASE	15
Table of Contents	15
Fetal long QT syndrome	15
PO-03-043 TRANS-BAFFLE INSERTION OF A LEADLESS PACEMAKER IN A PATIENT WITH EXTRACARDIAC FONTAN	15
PO-01-032 PERCUTANEOUS EXTRACTION OF A LARGE ORGANIZED LEFT ATRIAL THROMBUS WITH MECHANICAL ASPIRATION	15
Editorial Board	15